U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
190201190201Boron Neutron Capture Therapy in Treating Patients With MelanomaCompletedNo Results AvailableMelanoma (Skin)Radiation: boron neutron capture therapyhttps://ClinicalTrials.gov/show/NCT00059800
190202190202Combination Chemotherapy Plus Erlotinib in Treating Patients With Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal CancerCompletedNo Results AvailableBrenner Tumor|Fallopian Tube Cancer|Ovarian Clear Cell Cystadenocarcinoma|Ovarian Endometrioid Adenocarcinoma|Ovarian Mucinous Cystadenocarcinoma|Ovarian Serous Cystadenocarcinoma|Ovarian Undifferentiated Adenocarcinoma|Primary Peritoneal Cavity Cancer|StDrug: paclitaxel|Drug: carboplatin|Drug: erlotinib hydrochloride|Other: laboratory biomarker analysishttps://ClinicalTrials.gov/show/NCT00059787
190203190203Chemotherapy Combined With Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung CancerCompletedNo Results AvailableLung CancerDrug: cisplatin|Drug: irinotecan hydrochloride|Radiation: radiation therapyhttps://ClinicalTrials.gov/show/NCT00059761
190204190204Studies of the Natural History, Pathogenesis, and Outcome of Autoinflammatory Diseases (NOMID / CAPS, DIRA, CANDLE, SAVI, CRMO, Still's Disease, Behcet's Disease, and Other Undifferentiated Autoinflammatory Diseases)RecruitingNo Results AvailableUrticaria|Arthropathy|Lymphadenopathy|Nervous System Anomalieshttps://ClinicalTrials.gov/show/NCT00059748
190205190205A Safety, Tolerability and Efficacy Study of E7070 in Patients With Renal Cell CarcinomaCompletedNo Results AvailableKidney Neoplasms|Carcinoma, Renal Cell|Adenocarcinoma, Renal CellDrug: E7070https://ClinicalTrials.gov/show/NCT00059735
190206190206This Study is to Compare the Efficacy of ZD6474 and ZD1839 in Subjects With NSCLC.CompletedNo Results AvailableCarcinoma, Non-Small-Cell LungDrug: ZD6474|Drug: Placebo|Drug: ZD1839https://ClinicalTrials.gov/show/NCT00059722
190207190207Learning to Resolve Family ConflictCompletedNo Results AvailableConflict|Family RelationsProcedure: Mediated Negotiation Traininghttps://ClinicalTrials.gov/show/NCT00059709
190208190208Treatment for Movement Problems in Elderly Stroke PatientsWithdrawnNo Results AvailableCerebrovascular DisordersProcedure: Constraint-Induced Movement Therapyhttps://ClinicalTrials.gov/show/NCT00059696
190209190209Ultrasound-indicated Cerclage to Prevent Premature Birth in High-risk WomenCompletedNo Results AvailableLabor, PrematureProcedure: cervical cerclagehttps://ClinicalTrials.gov/show/NCT00059683
190210190210Comparison of Two Therapies for Upper Esophageal Sphincter (UES) DysphagiaCompletedNo Results AvailableDeglutition DisordersProcedure: Shaker Exercise vs. Traditional Dysphagia Therapy Regimehttps://ClinicalTrials.gov/show/NCT00059670
190211190211Efficacy/Safety of Ecraprost in Lipid Emulsion for Treatment of Critical Leg Ischemia Due to Peripheral Arterial DiseaseCompletedNo Results AvailablePeripheral Vascular DiseaseDrug: Ecraprost in lipid emulsionhttps://ClinicalTrials.gov/show/NCT00059657
190212190212Efficacy/Safety of Ecraprost in Lipid Emulsion for Treatment of Critical Leg Ischemia Due to Peripheral Arterial DiseaseTerminatedNo Results AvailablePeripheral Vascular DiseaseDrug: Ecraprost in lipid emulsionhttps://ClinicalTrials.gov/show/NCT00059644
190213190213Phase I Study of Weekly Intravenous PS-341 (Bortezomib) Plus MitoxantroneCompletedNo Results AvailableProstate CancerDrug: Mitoxantrone (Novantrone)|Drug: Bortezomib (PS-341)https://ClinicalTrials.gov/show/NCT00059631
190214190214PS-341 Plus Carboplatin in Platinum and Taxane Resistant Recurrent Ovarian Cancer, Primary Peritoneal Cancer, and Fallopian Tube CancerCompletedNo Results AvailableOvarian Cancer|Primary Peritoneal Cancer|Fallopian Tube CancerDrug: PS-341 (Bortezomib)|Drug: Carboplatinhttps://ClinicalTrials.gov/show/NCT00059618
190215190215Phase I Study of IV DOTAP: Cholesterol-Fus1 in Non-Small-Cell Lung CancerCompletedNo Results AvailableLung CancerGenetic: DOTAP:Chol-fus1https://ClinicalTrials.gov/show/NCT00059605
190216190216Valacyclovir in Immunocompromised ChildrenCompletedNo Results AvailableShingles|Bone Marrow TransplantationDrug: Valacyclovirhttps://ClinicalTrials.gov/show/NCT00059592
190217190217Brain Regulation of Emotions in People With Depression and AnhedoniaCompletedNo Results AvailableMajor Depressive Disorderhttps://ClinicalTrials.gov/show/NCT00059579
190218190218Retraining Walking After Spinal Cord InjuryActive, not recruitingNo Results AvailableSpinal Cord Injuries|Quadriplegia|Paraplegia|Central Cord Syndrome|Brown-Sequard SyndromeBehavioral: Locomotor treadmill training with body weight supporthttps://ClinicalTrials.gov/show/NCT00059553
190219190219The Maternal Lifestyle Study (MLS)Active, not recruitingNo Results AvailableCocaine|Substance Abuse|Infant, Newborn|Pregnancy|Pregnant Women|Prenatal Carehttps://ClinicalTrials.gov/show/NCT00059540
190220190220Healthy Youth Places: A Program to Promote Nutrition and Physical Activity in AdolescentsCompletedNo Results AvailableHealth BehaviorBehavioral: Healthy Youth Places: a behavior change modelhttps://ClinicalTrials.gov/show/NCT00059527
190221190221Tobacco Use Among Arab American YouthRecruitingNo Results AvailableTobacco Use DisorderBehavioral: Modified Project Toward No Tobacco Usehttps://ClinicalTrials.gov/show/NCT00059514
190222190222Postural Control in the ElderlyCompletedNo Results AvailableMusculoskeletal Physiology|Healthyhttps://ClinicalTrials.gov/show/NCT00059501
190223190223Peptide Vaccination for Patients at High Risk for Recurrent MelanomaCompletedHas ResultsMelanomaDrug: Glycoprotein 100 (GP100): 209-217 (210M)|Drug: Interleukin-2 (IL-2)|Drug: Montanide ISA 51|Drug: Melanoma antigen recognized by T-cells (MART)-1: 27-35|Drug: 27-35 (27L): melanoma antigen recognized by T-cells (MART)-1|Drug: melanoma antigen recognized by T-cells (MART)-1: 26-35(27L)https://ClinicalTrials.gov/show/NCT00059475
190224190224Safety and Efficacy of BAY 50-4798 in Patients With HIV InfectionCompletedNo Results AvailableHIV InfectionsDrug: Interleukin-2 SA|Drug: HAARThttps://ClinicalTrials.gov/show/NCT00059462
190225190225Role of Epidermal Growth Factor (EGF) in Development of Necrotizing EnterocolitisCompletedNo Results AvailableNecrotizing Enterocolitis|Premature Birthhttps://ClinicalTrials.gov/show/NCT00059449
190226190226Mental Effort and Muscle StrengthWithdrawnNo Results AvailableAging|Muscle StrengthBehavioral: Mental effort in muscle strengtheninghttps://ClinicalTrials.gov/show/NCT00059436
190227190227Gene Message (mRNA) Analysis of GranulocytesRecruitingNo Results AvailableNeutropeniahttps://ClinicalTrials.gov/show/NCT00059423
190228190228Alzheimer's Disease Treatment and Illness Perceptions Survey (TIPS) IICompletedNo Results AvailableAlzheimer Diseasehttps://ClinicalTrials.gov/show/NCT00059410
190229190229Hepatitis C: Grading and Staging by MRCompletedNo Results AvailableHepatitishttps://ClinicalTrials.gov/show/NCT00059397
190230190230Alternative Dosing Strategy for Anti-HIV DrugsCompletedNo Results AvailableHIV InfectionsBehavioral: Concentration-controlled therapyhttps://ClinicalTrials.gov/show/NCT00059384

* Görseller ve İçerik tekif hakkına sahip olabilir